AFFLUENT MEDICAL SAS EO 1
Affluent Medical SA, a medical technology company, develops and markets minimally invasive minimally invasive medical devices in the field of urology and structural heart in France. The company offers Artus, an implantable electro-mechanical artificial sphincter that targets moderate to severe urinary incontinence; and Kalios and Epygon implants for the treatment of mitral insufficiency, as well … Read more
Market Cap & Net Worth: AFFLUENT MEDICAL SAS EO 1 (0JZ)
AFFLUENT MEDICAL SAS EO 1 (F:0JZ) has a market capitalization of $108.50 Million (€105.70 Million) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #23567 globally and #2577 in its home market, demonstrating a -15.14% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying AFFLUENT MEDICAL SAS EO 1's stock price €2.69 by its total outstanding shares 39295519 (39.30 Million).
AFFLUENT MEDICAL SAS EO 1 Market Cap History: 2021 to 2026
AFFLUENT MEDICAL SAS EO 1's market capitalization history from 2021 to 2026. Data shows change from $223.46 Million to $108.50 Million (-20.07% CAGR).
AFFLUENT MEDICAL SAS EO 1 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how AFFLUENT MEDICAL SAS EO 1's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 0JZ by Market Capitalization
Companies near AFFLUENT MEDICAL SAS EO 1 in the global market cap rankings as of March 18, 2026.
Key companies related to AFFLUENT MEDICAL SAS EO 1 by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
AFFLUENT MEDICAL SAS EO 1 Historical Marketcap From 2021 to 2026
Between 2021 and today, AFFLUENT MEDICAL SAS EO 1's market cap moved from $223.46 Million to $ 108.50 Million, with a yearly change of -20.07%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €108.50 Million | +63.03% |
| 2025 | €66.55 Million | +30.43% |
| 2024 | €51.02 Million | -24.25% |
| 2023 | €67.36 Million | +0.72% |
| 2022 | €66.88 Million | -70.07% |
| 2021 | €223.46 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of AFFLUENT MEDICAL SAS EO 1 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $108.50 Million USD |
| MoneyControl | $108.50 Million USD |
| MarketWatch | $108.50 Million USD |
| marketcap.company | $108.50 Million USD |
| Reuters | $108.50 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.